Evidence map›Paper›PMID 35615431›Full record

ArticleHeliyon2022

Association between kratom (

Aroon La-Up, Paleeratana Wongrith, Wiraphon Chaichan, Apinun Aramrattana, Udomsak Saengow

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The effects of kratomFrontiers in pharmacology · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Clinical Implications of Kratom (Current addiction reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aroon La-UpSchool of Public Health, Walailak University, Thai Buri, Tha Sala, Nakhon Si Thammarat, 80160, Thailand.
Paleeratana WongrithSchool of Public Health, Walailak University, Thai Buri, Tha Sala, Nakhon Si Thammarat, 80160, Thailand.
Wiraphon ChaichanNarcotics Crop Survey and Monitoring Institute, Office of the Narcotics Control Board, Samsen Nai, Phaya Thai, Bangkok, 10400, Thailand.
Apinun AramrattanaNorthern Substance Abuse Center, Department of Family Medicine, Chiang Mai University, Sri Phum, Muang, Chiang Mai, 50200, Thailand.
Udomsak SaengowCenter of Excellence in Data Science for Health Study, Walailak University, Thai Buri, Tha Sala, Nakhon Si Thammarat, 80160, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: There are evidence about effects of kratom ( Methods: This study is a cross-sectional study of 581 subjects (kratom users and non-users) aged 18 and over from the Nam Phu sub-district, Surat Thani province, Thailand. The association was determined using multivariate logistic regression. Results: MetS prevalence in kratom users and non-users was 11.9% (95% CI, 8.4-16.3%) and 21.6 % (95% CI, 17.1-26.8%), respectively. The use of kratom was associated with the lower odds of MetS (adjusted OR, 0.56; 95% CI, 0.33-0.96). Kratom use were associated with smaller waist circumference, lower triglycerides, and higher high-density lipoprotein. Conclusions: The current study demonstrated a potential protective effect of kratom use against MetS.

Indexed as

High-density lipoproteinKratomKratom consumptionMetabolic syndromeTriglyceridesWaist circumference

Identifiers

PMID35615431
PMCPMC9124704

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.